help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alam, S.
Right arrow Articles by Umpleby, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alam, S.
Right arrow Articles by Umpleby, A. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 688-694
Copyright © 2004 by The Endocrine Society

The Effect of a Six-Month Exercise Program on Very Low-Density Lipoprotein Apolipoprotein B Secretion in Type 2 Diabetes

Saima Alam, Michael Stolinski, Claire Pentecost, Massoud A. Boroujerdi, Richard H. Jones, Peter H. Sonksen and A. Margot Umpleby

Department of Diabetes, Endocrinology, and Internal Medicine, St. Thomas’ Hospital, Guys, Kings and St. Thomas’ School of Medicine, Kings College, London SE1 7EH, United Kingdom

Address all correspondence and requests for reprints to: Dr. A. M. Umpleby, Department of Diabetes, Endocrinology, and Internal Medicine, 4th Floor, North Wing, St. Thomas’ Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom. E-mail: margot.umpleby{at}kcl.ac.uk.

The dyslipidemia and insulin resistance of type 2 diabetes can be improved by aerobic exercise. The effect of 6 months supervised exercise on very low-density lipoprotein (VLDL) apolipoprotein B metabolism was investigated in patients with type 2 diabetes. Moderately obese patients (n = 18) were randomized into supervised (n = 9) and unsupervised (n = 9) exercise groups. All patients were given a training session and a personal exercise program and asked to exercise four times per week at 70% maximal oxygen uptake for 6 months. Patients in the supervised group had a weekly session with an exercise trainer. VLDL apolipoprotein (apo)B metabolism was measured with an infusion of 1-13C leucine before and after 6 months of the exercise program.

Supervised exercise for 6 months resulted in a significant within-group decrease in percent hemoglobin A1c (P < 0.001), body fat (P < 0.004), nonesterified fatty acid (P < 0.04), and triglycerides (P < 0.05) and an increase in insulin sensitivity (P < 0.01). There was a decrease in VLDL apoB pool size (160.8 ± 42.6 to 84.9 ± 23.2 mg, P < 0.01) and VLDL apoB secretion rate (11.3 ± 2.6 to 5.5 ± 2.0 mg/kg·d, P < 0.05) with no change in fractional catabolic rate. In a between-group comparison, the decrease in VLDL apoB secretion rate in the supervised group did not achieve significance. This study demonstrates that in type 2 diabetes, a supervised exercise program reduces VLDL apoB pool size, which may be due to a decrease in VLDL apoB secretion rate.

This work was supported by a grant from the British Heart Foundation (PG/2000056). S.A. was supported by a grant from the government of Pakistan.

Abbreviations: apoB, Apolipoprotein B; ASR, absolute secretion rate; CV, coefficient of variation; CVD, cardiovascular disease; FCR, fractional catabolic rate; FSR, fractional secretion rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HDL-C, HDL cholesterol; HOMAIR, insulin resistance calculated using homeostasis assessment model; {alpha}-KIC, {alpha}-ketoisocaproic acid; LDL, low-density lipoprotein; MTP, microsomal transfer protein; NEFA, nonesterified fatty acid; TG, triglyceride VLDL, very LDL; VO2max, maximal oxygen uptake.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Duez, B. Lamarche, K. D. Uffelman, R. Valero, L. Szeto, S. Lemieux, J. S. Cohn, and G. F. Lewis
Dissociation between the Insulin-Sensitizing Effect of Rosiglitazone and Its Effect on Hepatic and Intestinal Lipoprotein Production
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1722 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. J. Snowling and W. G. Hopkins
Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis.
Diabetes Care, November 1, 2006; 29(11): 2518 - 2527.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. B. Carr, K. M. Utzschneider, E. J. Boyko, P. J. Asberry, R. L. Hull, K. Kodama, H. S. Callahan, C. C. Matthys, D. L. Leonetti, R. S. Schwartz, et al.
A Reduced-Fat Diet and Aerobic Exercise in Japanese Americans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not {beta}-Cell Function
Diabetes, February 1, 2005; 54(2): 340 - 347.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society